GERMAINE HAWKINS: Open Payments
NPI 1417900887 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 39 payments from 10 companies in 2025. Trend: 2023 $578 · 2024 $1,087 · 2025 $1,151
Food & beverage: $937Travel & lodging: $215
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 25 | $753 |
| Alkermes, Inc. | 2 | $145 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Validus Pharmaceuticals LLC | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: SPRAVATO, ARISTADA, INVEGA SUSTENNA, REXULTI, CAPLYTA, Auvelity, EQUETRO, COBENFY.
Industry payments across TX — which companies pay providers there.
